Charles River Laboratories International, Inc. (FRA:RV6)

Market Cap	7.23B +16.4%
Revenue (ttm)	3.50B +0.1%
Net Income	-160.28M
EPS	-3.26
Shares Out	n/a
PE Ratio	n/a
Forward PE	14.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	149.85
Previous Close	155.60
Day's Range	149.85 - 149.85
52-Week Range	117.65 - 193.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 7, 2026

About FRA:RV6

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, ins...

• Industry: Commercial Physical and Biological Research
• Founded: 1947
• Employees: 19,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RV6

Financial Performance

Financial numbers in USD